-
公开(公告)号:US20240150294A1
公开(公告)日:2024-05-09
申请号:US18546525
申请日:2022-02-17
IPC分类号: C07D221/20 , A61K45/06 , A61P35/00 , C07D401/12
CPC分类号: C07D221/20 , A61K45/06 , A61P35/00 , C07D401/12
摘要: Provided is a compound of formula (I) or a pharmaceutically acceptable salt thereof, in which R1, R2, R3, R4, R5, X1, X2, and n are described herein. Also provided is a method of treating an estrogen-mediated disease requiring inhibition of estrogen receptor alpha (ER-alpha), such as cancer, in a subject or inhibiting ER-alpha in a cell with the compound of formula (I) or a pharmaceutically acceptable salt thereof.